Labopharm (DDS.TO) Adds Russia To Distribution And Licensing Agreement With CSC Pharmaceuticals Handels GmbH For Once-Daily Tramadol
10/19/2005 5:12:55 PM
LAVAL, QC, March 3 /CNW/ - Labopharm Inc. (TSX: DDS) today announced that its European subsidiary, Labopharm Europe Limited, has amended its licensing and distribution agreement with Austria-based CSC Pharmaceuticals Handels GmbH for once-daily tramadol to include Russia. The amendment increases the number of countries covered by the agreement to 15.
comments powered by